Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors

Clinical trial NCT00667394 · COMPLETED

Trial details

NCT number: NCT00667394
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligodendroglioma Anaplastic Mixed Oligoastrocytoma

Start date: 2008-04-01
Primary completion: 2011-07-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.